EYEGEN Trademark

Trademark Overview


On Thursday, January 15, 2026, a trademark application was filed for EYEGEN with the United States Patent and Trademark Office. The USPTO has given the EYEGEN trademark a serial number of 99596229. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, May 20, 2026. This trademark is owned by Samaritan Biologics, LLC. The EYEGEN trademark is filed in the Pharmaceutical Products category with the following description:

Human allograft tissue
eyegen

General Information


Serial Number99596229
Word MarkEYEGEN
Filing DateThursday, January 15, 2026
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateWednesday, May 20, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 9, 2026

Trademark Statements


Goods and ServicesHuman allograft tissue

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 15, 2026
Primary Code005
First Use Anywhere DateTuesday, August 11, 2020
First Use In Commerce DateTuesday, August 11, 2020

Trademark Owner History


Party NameSamaritan Biologics, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCordova, TN 38018
US

Trademark Events


Event DateEvent Description
Thursday, January 15, 2026NEW APPLICATION ENTERED
Thursday, January 15, 2026APPLICATION FILING RECEIPT MAILED
Thursday, January 15, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 13, 2026ASSIGNED TO EXAMINER
Thursday, May 14, 2026APPROVED FOR PUB - PRINCIPAL REGISTER

Related Keywords


eyegen tissue allograft human